Related references
Note: Only part of the references are listed.Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
Bianca D. Santomasso et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The impact of granulocyte colony stimulating factor on patients receiving chimeric antigen receptor T-cell therapy
Jason N. Barreto et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses
Juliet Meir et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Ibrahim Yakoub-Agha et al.
HAEMATOLOGICA (2020)
Hematopoietic Growth Factors Version 1.2020 Featured Updates to the NCCN Guidelines
Pamela Sue Becker et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators
Mohit Sachdeva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy
Kevin A. Hay et al.
BLOOD (2017)
G-CSF and GM-CSF in Neutropenia
Hrishikesh M. Mehta et al.
JOURNAL OF IMMUNOLOGY (2015)
Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice
M. Battiwalla et al.
BONE MARROW TRANSPLANTATION (2009)
G-CSF as immune regulator in T cells expressing the G-CSF receptor:: implications for transplantation and autoimmune diseases
A Franzke et al.
BLOOD (2003)
Share Paper
